Leash Biosciences Secures $9.3M Seed Funding to Revolutionize Drug Discovery with AI

Leash Biosciences aims to revolutionize medicinal chemistry with AI.

Source: Leash Biosciences

Company Name: Leash Biosciences
Location: Salt Lake City, UT
Sector: Biotechnology
Funding Details: Raised $9.3M in Seed funding from Springtide Ventures, MetaPlanet, Top Harvest Capital, Mitsui Global Investment, MFV Partners, and Recursion co-founders.
Purpose of Investment: To develop a foundational machine learning model of medicinal chemistry for predicting small molecule drug candidates.
Leadership: Led by CEO Ian Quigley.

Product: A platform that leverages machine learning to design novel small molecule therapeutics by analyzing chemical and biological datasets.

About Company: Leash Biosciences aims to revolutionize medicinal chemistry with AI. Having generated over 17 billion protein-chemical interaction measurements, the company plans to screen 500+ protein targets against millions of proprietary chemicals by 2025.

Neocis Raises $20M for Expansion of its Innovative Robot-Assisted Dental Surgery Platform, Yomi

Neocis specializes in the field of robot-assisted dental surgery.

Visa Announces $100M Generative AI Ventures Initiative to Shape the Future of Commerce and Payments

Visa will invest in the next generation of companies focused on developing generative AI.

Navigating the Forefront of Cybersecurity: 4 Investments in AI Changing cybersecurity

These are the recent largest funding announcements in AI cybersecurity.

Read next